ORAL THERAPY SHOWS POTENTIAL TO PROTECT HEALTHY TISSUE FROM RADIATION

BLACKSBURG, Va., Aug. 21 -- Virginia Polytechnic Institute and State University issued the following news release:

Researchers at the Fralin Biomedical Research Institute at VTC have developed an experimental oral therapy that protected mice from otherwise harmful radiation exposure while preserving radiation's ability to destroy cancer cells, a finding that could ultimately improve cancer treatment and strengthen preparedness for radiological emergencies.

Published in the September issue ofCancer Letters, the study describes an investigational therapy called XOlacta that packages a therapeutic peptide known as alpha-CT11 inside naturally occurring milk-derived extracellular vesicles, which are tiny, naturally occurring particles that cel...